ErbB Family Signalling: A Paradigm for Oncogene Addiction and Personalized Oncology

Cancers - Switzerland
doi 10.3390/cancers9040033
Full Text
Abstract

Available in full text

Date
Authors
Publisher

MDPI AG

Related search

Tyrosine Kinase Signalling in Breast Cancer: ErbB Family Receptor Tyrosine Kinases

Breast Cancer Research
Cancer ResearchOncology
2000English

Experimental Therapeutics: A Paradigm for Personalized Medicine

Clinical and Translational Science
GeneticsMolecular BiologyPharmacologyBiochemistryNeuroscienceMedicineToxicologyPharmaceutics
2009English

Reinventing Diagnostics for Personalized Therapy in Oncology

Cancers
Cancer ResearchOncology
2010English

Decision Support Systems for Personalized and Participative Radiation Oncology

Advanced Drug Delivery Reviews
Pharmaceutical Science
2017English

New Paradigm of Machine Learning (ML) in Personalized Oncology: Data Trimming for Squeezing More Biomarkers From Clinical Datasets

Frontiers in Oncology
Cancer ResearchOncology
2019English

Personalized Oncology in Interventional Radiology

Journal of Vascular and Interventional Radiology
Nuclear MedicineRadiologyCardiologyCardiovascular MedicineImagingMedicine
2013English

Immuno-Oncology Biomarkers for Personalized Immunotherapy in Breast Cancer

Frontiers in Cell and Developmental Biology
Developmental BiologyCell Biology
2020English

A View on EGFR-targeted Therapies From the Oncogene-Addiction Perspective

Frontiers in Pharmacology
Pharmacology
2013English

Interplay Between HSF1 and P53 Signaling Pathways in Cancer Initiation and Progression: Non-Oncogene and Oncogene Addiction

Cellular Oncology
MedicineCancer ResearchOncologyMolecular Medicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy